=Acadia Pharmaceuticals Inc. (ACAD) reported earnings on Tue 8 Nov 2016 (b/o)

SAN DIEGO (AP) _ Acadia Pharmaceuticals Inc. (ACAD) on Monday reported a loss of $71.6 million in its third quarter.

On a per-share basis, the San Diego-based company said it had a loss of 61 cents. Losses, adjusted for stock option expense, were 49 cents per share.

The results topped Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 55 cents per share.

The drugmaker posted revenue of $5.3 million in the period.

Acadia shares have declined 36 percent since the beginning of the year. In the final minutes of trading on Monday, shares hit $22.99, a fall of 45 percent in the last 12 months.